Baker Bros. Advisors LP Protara Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
A detailed history of Baker Bros. Advisors LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 536,832 shares of TARA stock, worth $1.64 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
536,832
Previous 536,832
-0.0%
Holding current value
$1.64 Million
Previous $2.82 Million
18.88%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding TARA
# of Institutions
65Shares Held
28.4MCall Options Held
365KPut Options Held
108K-
Janus Henderson Group PLC London, X03.79MShares$11.6 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.4MShares$10.4 Million0.3% of portfolio
-
Blackstone Inc New York, NY1.74MShares$5.34 Million0.03% of portfolio
-
Opaleye Management Inc. Boston, MA1.73MShares$5.29 Million2.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA1.67MShares$5.1 Million12.25% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $34.5M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...